These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32375395)
21. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas. Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382 [TBL] [Abstract][Full Text] [Related]
22. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
23. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome]. Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301 [TBL] [Abstract][Full Text] [Related]
24. Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Lin Z; Hegarty JP; Cappel JA; Yu W; Chen X; Faber P; Wang Y; Kelly AA; Poritz LS; Peterson BZ; Schreiber S; Fan JB; Koltun WA Clin Genet; 2011 Jul; 80(1):59-67. PubMed ID: 20950376 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India. Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608 [TBL] [Abstract][Full Text] [Related]
26. Association of Aberrant Promoter Methylation Changes in the Suppressor of Cytokine Signaling 3 Sanati G; Jafari D; Noruzinia M; Ebrahimi Daryani N; Ahmadvand M; Teimourian S; Rezaei N Avicenna J Med Biotechnol; 2022; 14(2):165-169. PubMed ID: 35633985 [TBL] [Abstract][Full Text] [Related]
27. Methylation status of the Xu XJ; Gao S; Wang M; Qian H; Gu GY; Zhang K; Xu WR Oncol Lett; 2015 Jun; 9(6):2661-2666. PubMed ID: 26137124 [TBL] [Abstract][Full Text] [Related]
29. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients. Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757 [TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma]. Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654 [TBL] [Abstract][Full Text] [Related]
31. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635 [TBL] [Abstract][Full Text] [Related]
32. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma. Takada S; Morita K; Hayashi K; Matsushima T; Sawamura M; Murakami H; Nojima Y Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263 [TBL] [Abstract][Full Text] [Related]
33. Mucosal DNA methylome alteration in Crohn's disease: surgical and non-surgical groups. Ahmad S; Sands M; Greenberg E; Tangen L; Huang J; Irudayaraj JMK Front Genet; 2023; 14():1244513. PubMed ID: 38046046 [TBL] [Abstract][Full Text] [Related]
34. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers. Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271 [TBL] [Abstract][Full Text] [Related]
35. Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL). Mohammad F; Pandith AA; Rasool SUA; Guru FR; Qasim I; Geelani S; Nisar S; Baba SM; Ganie FA; Kouser S; Rasool J Discov Oncol; 2024 Apr; 15(1):108. PubMed ID: 38587694 [TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis of DNA methylation profile identifies differentially methylated loci associated with human intervertebral disc degeneration. Ikuno A; Akeda K; Takebayashi SI; Shimaoka M; Okumura K; Sudo A PLoS One; 2019; 14(9):e0222188. PubMed ID: 31513634 [TBL] [Abstract][Full Text] [Related]
37. FHIT expression and hypermethylation in esophageal squamous cell carcinoma. Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095 [TBL] [Abstract][Full Text] [Related]
38. Genome-wide DNA methylation profiling of hip articular cartilage identifies differentially methylated loci associated with osteonecrosis of the femoral head. Wu J; Du Y; Song J; Dang X; Wang K; Wen Y; Zhang F; Liu R Bone; 2019 Oct; 127():296-304. PubMed ID: 31233934 [TBL] [Abstract][Full Text] [Related]
39. Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients. Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ Int J Gynecol Cancer; 2006; 16(5):1862-7. PubMed ID: 17009983 [TBL] [Abstract][Full Text] [Related]
40. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]